Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Abnormalities, Digestive System”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04837963
What this trial is testing

Does Hirschsprung Disease Increase the Risk of Febrile Urinary Tract Infection in Children

Who this might be right for
Hirschsprung DiseaseFebrile Urinary Tract Infection (Disorder)
University Hospital, Montpellier 630
Not applicableStudy completedNCT07088614
What this trial is testing

Effectiveness of Respiratory Physiotherapy on Frequency of Exacerbations, Lung Function and Quality of Life After 6 Months in Children With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
University of Americas 9
Not applicableStudy completedNCT05140967
What this trial is testing

Effects of Training Intensity on Physical Fitness and Body Composition in Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
University of Kiel 70
Large-scale testing (Phase 3)Study completedNCT03941236
What this trial is testing

Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital Hyperinsulinism

Who this might be right for
Congenital Hyperinsulinism
Zealand Pharma 42
Early research (Phase 1)Study completedNCT06299709
What this trial is testing

Evaluate the Relative Bioavailability, Food Effect, and Dose Proportionality of a Granule Formulation of Vanzacaftor/Tezacaftor/Deutivacaftor(VNZ/TEZ/D-IVA)

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 34
Large-scale testing (Phase 3)Study completedNCT02934698
What this trial is testing

An Efficacy and Safety Study of Ivacaftor in Patients With Cystic Fibrosis and Two Splicing Mutations

Who this might be right for
Cystic Fibrosis
Medical University of South Carolina 2
Not applicableStudy completedNCT02299739
What this trial is testing

Liver Enzyme Abnormalities and Risk Factors in Taking Herbal Medicine

Who this might be right for
Drug-Induced Liver InjuryMusculoskeletal Diseases
Jaseng Hospital of Korean Medicine 6,894
Large-scale testing (Phase 3)Study completedNCT01807923
What this trial is testing

Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation

Who this might be right for
Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
Vertex Pharmaceuticals Incorporated 559
Not applicableStudy completedNCT01593631
What this trial is testing

Acid Lactase in Combination With Yoghurt Bacteria for Improvement of Lactose Digestion in Lactose Malabsorbers

Who this might be right for
Lactose Malabsorption
Vitacare Gmbh & Co. KG 24
Not applicableWithdrawnNCT03261219
What this trial is testing

IPV vs CPT for Airway Clearance During CF Exacerbation

Who this might be right for
Cystic FibrosisAirway Clearance Impairment
University of Florida
Not applicableUnknownNCT04687319
What this trial is testing

RHEology of the Pulmonary MUcus

Who this might be right for
Bronchial Mucus in COPD and Cystic Fibrosis
University Hospital, Grenoble 100
Testing effectiveness (Phase 2)Study completedNCT01883531
What this trial is testing

Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 Years

Who this might be right for
Cystic Fibrosis
Syntara 95
Not applicableStudy completedNCT05367453
What this trial is testing

Effect of a Probiotic With High Beta-galactosidase Activity on Patients With Lactose Intolerance

Who this might be right for
Lactose Intolerance
Instituto de Investigación Hospital Universitario La Paz 40
Early research (Phase 1)Not Yet RecruitingNCT07813039
What this trial is testing

Relative Bioavailability Study of a VX-581 Tablet Formulation

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 16
Not applicableStudy completedNCT00392730
What this trial is testing

Neurodevelopment and Neuroimaging in Parenterally-fed Infants and Young Children

Who this might be right for
Parenteral NutritionNecrotizing EnterocolitisDigestive System Abnormalities+1 more
Vanderbilt University 122
Not applicableLooking for participantsNCT05723445
What this trial is testing

The Effects of a Low Glycemic Load Diet on Dysglycemia and Body Composition in Adults With Cystic Fibrosis-Related Diabetes

Who this might be right for
Cystic FibrosisCystic Fibrosis-related DiabetesCystic Fibrosis With Intestinal Manifestations
Rhode Island Hospital 15
Testing effectiveness (Phase 2)Study completedNCT02949830
What this trial is testing

Evaluate Long-term Safety and Clinical Activity of Givosiran (ALN-AS1) in Patient With Acute Intermittent Porphyria (AIP)

Who this might be right for
Acute Intermittent Porphyria
Alnylam Pharmaceuticals 16
Post-approval studies (Phase 4)Study completedNCT03961828
What this trial is testing

Hyalornic Acid Level in β-Thalassemic Children Treated for Hepatitis C Virus

Who this might be right for
Beta-ThalassemiaHepatitis C
Tanta University 50
Testing effectiveness (Phase 2)Study completedNCT05010577
What this trial is testing

Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection

Who this might be right for
Chronic Pseudomonas Aeruginosa InfectionCystic Fibrosis
BiomX, Inc. 43
Testing effectiveness (Phase 2)Study completedNCT01113619
What this trial is testing

Effectiveness, Safety and Tolerability Study of RP-G28 for Symptoms Associated With Lactose Intolerance

Who this might be right for
Lactose Intolerance
Ritter Pharmaceuticals, Inc. 61
Next Page